167 related articles for article (PubMed ID: 20470217)
1. Radioimmunotherapy for the treatment of non-Hodgkin lymphoma: current status and future applications.
Ahmed S; Winter JN; Gordon LI; Evens AM
Leuk Lymphoma; 2010 Jul; 51(7):1163-77. PubMed ID: 20470217
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunotherapy for indolent B-cell non-Hodgkin lymphoma in relapsed, refractory and transformed disease.
Visser OJ; Perk LR; Zijlstra JM; van Dongen GA; Huijgens PC; van de Loosdrecht AA
BioDrugs; 2006; 20(4):201-7. PubMed ID: 16831019
[TBL] [Abstract][Full Text] [Related]
3. Iodine-131 rituximab radioimmunotherapy with BEAM conditioning and autologous stem cell transplant salvage therapy for relapsed/refractory aggressive non-Hodgkin lymphoma.
Kruger PC; Cooney JP; Turner JH
Cancer Biother Radiopharm; 2012 Nov; 27(9):552-60. PubMed ID: 23062193
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunotherapy for B-cell non-hodgkin lymphomas.
Tomblyn M
Cancer Control; 2012 Jul; 19(3):196-203. PubMed ID: 22710895
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunotherapy for non-hodgkin lymphoma : historical perspective and current status.
Emmanouilides C
J Clin Exp Hematop; 2007 Nov; 47(2):43-60. PubMed ID: 18040144
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunotherapy for Non-Hodgkin's Lymphoma.
Rao AV; Akabani G; Rizzieri DA
Clin Med Res; 2005 Aug; 3(3):157-65. PubMed ID: 16160070
[TBL] [Abstract][Full Text] [Related]
7. The role of radioimmunotherapy with yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma.
Cheson BD
BioDrugs; 2005; 19(5):309-22. PubMed ID: 16207072
[TBL] [Abstract][Full Text] [Related]
8. Non-myeloablative radioimmunotherapy for non-Hodgkin's lymphoma.
Schaefer-Cutillo J; Friedberg JW
Semin Hematol; 2008 Apr; 45(2):110-7. PubMed ID: 18381106
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunotherapy in non-Hodgkin lymphoma: Prediction and assessment of response.
Eskian M; Khorasanizadeh M; Kraeber-Bodere F; Rezaei N
Crit Rev Oncol Hematol; 2016 Nov; 107():182-189. PubMed ID: 27823646
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunotherapy as the first line of treatment in non-Hodgkin lymphoma.
Eskian M; Khorasanizadeh M; Zinzani PL; Rezaei N
Immunotherapy; 2018 Jun; 10(8):699-711. PubMed ID: 29569511
[TBL] [Abstract][Full Text] [Related]
11. Novel Methods to Improve the Efficiency of Radioimmunotherapy for Non-Hodgkin Lymphoma.
Eskian M; Khorasanizadeh M; Zinzani PL; Illidge TM; Rezaei N
Int Rev Immunol; 2019; 38(2):79-91. PubMed ID: 30931651
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunotherapy for stem cell transplantation in non-Hodgkin's lymphoma: in pursuit of a complete response.
Gisselbrecht C; Vose J; Nademanee A; Gianni AM; Nagler A
Oncologist; 2009; 14 Suppl 2():41-51. PubMed ID: 19819923
[TBL] [Abstract][Full Text] [Related]
13. Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials.
Wiseman GA; Kornmehl E; Leigh B; Erwin WD; Podoloff DA; Spies S; Sparks RB; Stabin MG; Witzig T; White CA
J Nucl Med; 2003 Mar; 44(3):465-74. PubMed ID: 12621016
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric Approaches for Radioimmunotherapy of Non-Hodgkin Lymphoma in Myeloablative Setting.
Cicone F; Sarnelli A; Guidi C; Belli ML; Ferrari ME; Wahl R; Cremonesi M; Paganelli G
Semin Nucl Med; 2022 Mar; 52(2):191-214. PubMed ID: 34996594
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunotherapy of non-Hodgkin's lymphoma: from the 'magic bullets' to 'radioactive magic bullets'.
Chamarthy MR; Williams SC; Moadel RM
Yale J Biol Med; 2011 Dec; 84(4):391-407. PubMed ID: 22180677
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of radioimmunotherapy (RIT) in treatment of non-Hodgkin's lymphoma in the community setting.
Hadid T; Raufi A; Kafri Z; Mandziara M; Kalabat J; Szpunar S; Kolizeras K; Steigelman M; Al-Katib A
Nucl Med Biol; 2016 Apr; 43(4):227-31. PubMed ID: 27067042
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunotherapy in follicular lymphoma.
Illidge T; Morschhauser F
Best Pract Res Clin Haematol; 2011 Jun; 24(2):279-93. PubMed ID: 21658624
[TBL] [Abstract][Full Text] [Related]
18. Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs).
DeNardo GL
Semin Nucl Med; 2005 Jul; 35(3):202-11. PubMed ID: 16098294
[TBL] [Abstract][Full Text] [Related]
19. Radioimmunotherapy for B-cell non-Hodgkin lymphoma.
Witzig TE
Best Pract Res Clin Haematol; 2006; 19(4):655-68. PubMed ID: 16997175
[TBL] [Abstract][Full Text] [Related]
20. 131I-rituximab treatment in patient with relapsed non-Hodgkin's lymphoma: the first case report in Thailand.
Kositwattanarerk A; Changmuang W; Sangsuriyan J; Thongklam K; Sritara C; Utamakul C; Chamroonrat W; Thamnirat K; Anongpornyochkul Y; Chancharunee S
J Med Assoc Thai; 2013 Jun; 96(6):756-60. PubMed ID: 23951835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]